Search Results - "Shang, Yushuan"

Abstract 5087: ILB-3101, a novel B7H3-targeting ADC with Eribulin as payload, demonstrates strong tumor killing activities and favorable PK/TOX profile in preclinical evaluation by Shang, Yushuan, Qiu, Junzhuan, Xin, Yanfei, Zhao, Min, Liu, Qiang, Wang, Zhengsheng, Gong, Xiaojing, Xu, Yan, Li, Yan, Xia, Mingde, Chen, Rulei

“…B7H3, a B7 family member of immune checkpoint proteins, is overexpressed in a broad spectrum of malignant tumors. It has become an attractive target for cancer…”
Get full text

Cross‐neutralization of RBD mutant strains of SARS‐CoV‐2 by convalescent patient derived antibodies by Lou, Yan, Zhao, Wenxiang, Wei, Haitao, Chu, Min, Chao, Ruihua, Yao, Hangping, Su, Junwei, Li, Yanan, Li, Xiulan, Cao, Yu, Feng, Yanyan, Wang, Ping, Xia, Yongyang, Shang, Yushuan, Li, Fengping, Ge, Pingju, Zhang, Xinglin, Gao, Wenjing, Song, Gaojie, Du, Bing, Liang, Tingbo, Qiu, Yunqing, Liu, Mingyao

“…Background The emergence of COVID‐19 pandemic resulted in an urgent need for the development of therapeutic interventions. Of which, neutralizing antibodies…”
Get full text